APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Travelers Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Selected research

Industry Growth & Trends

Global Travelers Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174042870121 December 202598 pages

Choose your research edition.

Industry ResearchTravelers Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Travelers Vaccines Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Travelers Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Travelers Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Travelers Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Read the full market overview

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

Report Scope

This report provides a structured, data-driven view of the global Travelers Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Travelers Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Travelers Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toTravelers Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Travelers Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Travelers Vaccines Market by Company

GlaxoSmithKline

Sanofi Pasteur

Merck

Pfizer

CNBG

Sanofi Pasteur MSD

Serum Institute of India

Biokangtai

Travelers Vaccines Segment by Type

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Yellow Fever Vaccine

Hepatitis Vaccine

Cholera Vaccine

Other

Travelers Vaccines Segment by End Users

Tourists

Students

Workers

Others

Travelers Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Meningococcal Vaccine Table 2. Major Company of Japanese Encephalitis Vaccine Table 3. Major Company of Yellow Fever Vaccine Table 4. Major Company of Hepatitis Vaccine Table 5. Major Company of Cholera Vaccine Table 6. Major Company of Other Table 7. Global Travelers Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 9. Global Travelers Vaccines Sales Market Share in Volume by Type (2021-2026) Table 10. Global Travelers Vaccines Sales by Type (2021-2026) & (US$ Million) Table 11. Global Travelers Vaccines Sales Market Share in Value by Type (2021-2026) Table 12. Global Travelers Vaccines Price by Type (2021-2026) & (USD/dose) Table 13. Global Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 14. Global Travelers Vaccines Sales Market Share in Volume by Type (2027-2032) Table 15. Global Travelers Vaccines Sales by Type (2027-2032) & (US$ Million) Table 16. Global Travelers Vaccines Sales Market Share in Value by Type (2027-2032) Table 17. Global Travelers Vaccines Price by Type (2027-2032) & (USD/dose) Table 18. North America Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 19. North America Travelers Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 21. Europe Travelers Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 23. Asia-Pacific Travelers Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 25. Latin America Travelers Vaccines Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 27. Middle East and Africa Travelers Vaccines Sales by Type (2021-2026) & (US$ Million) Table 28. Travelers Vaccines Industry Trends Table 29. Travelers Vaccines Industry Drivers Table 30. Travelers Vaccines Industry Opportunities and Challenges Table 31. Travelers Vaccines Industry Restraints Table 32. Global Travelers Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Travelers Vaccines Revenue Market Share by Company (2021-2026) Table 34. Global Travelers Vaccines Sales by Company (2021-2026) & (k doses) Table 35. Global Travelers Vaccines Sales Share by Company (2021-2026) Table 36. Global Travelers Vaccines Market Price by Company (2021-2026) & (USD/dose) Table 37. Global Travelers Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Travelers Vaccines Major Company Production Sites and Headquarters Table 39. Global Travelers Vaccines Company, Product Type & Application Table 40. Global Travelers Vaccines Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Travelers Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Travelers Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Travelers Vaccines Sales by Region (2021-2026) & (k doses) Table 45. Global Travelers Vaccines Sales Market Share in Volume by Region (2021-2026) Table 46. Global Travelers Vaccines Sales by Region (2021-2026) & (US$ Million) Table 47. Global Travelers Vaccines Sales Market Share in Value by Region (2021-2026) Table 48. Global Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 49. Global Travelers Vaccines Sales by Region (2027-2032) & (k doses) Table 50. Global Travelers Vaccines Sales Market Share in Volume by Region (2027-2032) Table 51. Global Travelers Vaccines Sales by Region (2027-2032) & (US$ Million) Table 52. Global Travelers Vaccines Sales Market Share in Value by Region (2027-2032) Table 53. Global Travelers Vaccines Sales (k doses), Value (US$ Million), Price (USD/dose) and Gross Margin (2027-2032) Table 54. Global Travelers Vaccines Sales by End Users (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 56. Global Travelers Vaccines Sales Market Share in Volume by End Users (2021-2026) Table 57. Global Travelers Vaccines Sales by End Users (2021-2026) & (US$ Million) Table 58. Global Travelers Vaccines Sales Market Share in Value by End Users (2021-2026) Table 59. Global Travelers Vaccines Price by End Users (2021-2026) & (USD/dose) Table 60. Global Travelers Vaccines Sales by End Users (2027-2032) & (k doses) Table 61. Global Travelers Vaccines Sales Market Share in Volume by End Users (2027-2032) Table 62. Global Travelers Vaccines Sales by End Users (2027-2032) & (US$ Million) Table 63. Global Travelers Vaccines Sales Market Share in Value by End Users (2027-2032) Table 64. Global Travelers Vaccines Price by End Users (2027-2032) & (USD/dose) Table 65. North America Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 66. North America Travelers Vaccines Sales by End Users (2021-2026) & (US$ Million) Table 67. Europe Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 68. Europe Travelers Vaccines Sales by End Users (2021-2026) & (US$ Million) Table 69. Asia-Pacific Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 70. Asia-Pacific Travelers Vaccines Sales by End Users (2021-2026) & (US$ Million) Table 71. Latin America Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 72. Latin America Travelers Vaccines Sales by End Users (2021-2026) & (US$ Million) Table 73. Middle East and Africa Travelers Vaccines Sales by End Users (2021-2026) & (k doses) Table 74. Middle East and Africa Travelers Vaccines Sales by End Users (2021-2026) & (US$ Million) Table 75. GlaxoSmithKline Company Information Table 76. GlaxoSmithKline Business Overview Table 77. GlaxoSmithKline Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 78. GlaxoSmithKline Travelers Vaccines Product Portfolio Table 79. GlaxoSmithKline Recent Development Table 80. Sanofi Pasteur Company Information Table 81. Sanofi Pasteur Business Overview Table 82. Sanofi Pasteur Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 83. Sanofi Pasteur Travelers Vaccines Product Portfolio Table 84. Sanofi Pasteur Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 88. Merck Travelers Vaccines Product Portfolio Table 89. Merck Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 93. Pfizer Travelers Vaccines Product Portfolio Table 94. Pfizer Recent Development Table 95. CNBG Company Information Table 96. CNBG Business Overview Table 97. CNBG Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 98. CNBG Travelers Vaccines Product Portfolio Table 99. CNBG Recent Development Table 100. Sanofi Pasteur MSD Company Information Table 101. Sanofi Pasteur MSD Business Overview Table 102. Sanofi Pasteur MSD Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 103. Sanofi Pasteur MSD Travelers Vaccines Product Portfolio Table 104. Sanofi Pasteur MSD Recent Development Table 105. Serum Institute of India Company Information Table 106. Serum Institute of India Business Overview Table 107. Serum Institute of India Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 108. Serum Institute of India Travelers Vaccines Product Portfolio Table 109. Serum Institute of India Recent Development Table 110. Biokangtai Company Information Table 111. Biokangtai Business Overview Table 112. Biokangtai Travelers Vaccines Sales (k doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2021-2026) Table 113. Biokangtai Travelers Vaccines Product Portfolio Table 114. Biokangtai Recent Development Table 115. North America Travelers Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 116. North America Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 117. North America Travelers Vaccines Sales Market Share by Country (2021-2026) Table 118. North America Travelers Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 119. North America Travelers Vaccines Sales Market Share Forecast by Country (2027-2032) Table 120. North America Travelers Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Travelers Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Travelers Vaccines Market Share by Country (2021-2026) Table 123. North America Travelers Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Travelers Vaccines Market Share Forecast by Country (2027-2032) Table 125. Europe Travelers Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 126. Europe Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 127. Europe Travelers Vaccines Sales Market Share by Country (2021-2026) Table 128. Europe Travelers Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 129. Europe Travelers Vaccines Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Travelers Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Travelers Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Travelers Vaccines Market Share by Country (2021-2026) Table 133. Europe Travelers Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Travelers Vaccines Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Travelers Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 137. Asia-Pacific Travelers Vaccines Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Travelers Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 139. Asia-Pacific Travelers Vaccines Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Travelers Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Travelers Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Travelers Vaccines Market Share by Country (2021-2026) Table 143. Asia-Pacific Travelers Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Travelers Vaccines Market Share Forecast by Country (2027-2032) Table 145. Latin America Travelers Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 146. Latin America Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 147. Latin America Travelers Vaccines Sales Market Share by Country (2021-2026) Table 148. Latin America Travelers Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 149. Latin America Travelers Vaccines Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Travelers Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Travelers Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Travelers Vaccines Market Share by Country (2021-2026) Table 153. Latin America Travelers Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Travelers Vaccines Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Travelers Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 157. Middle East and Africa Travelers Vaccines Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Travelers Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 159. Middle East and Africa Travelers Vaccines Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Travelers Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Travelers Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Travelers Vaccines Market Share by Country (2021-2026) Table 163. Middle East and Africa Travelers Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Travelers Vaccines Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Travelers Vaccines Distributors List Table 168. Travelers Vaccines Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Travelers Vaccines Image Figure 2. Global Travelers Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Travelers Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Travelers Vaccines Sales (2021-2032) & (k doses) Figure 5. Meningococcal Vaccine Image Figure 6. Global Meningococcal Vaccine Sales YoY Growth (2021-2032) & (k doses) Figure 7. Japanese Encephalitis Vaccine Image Figure 8. Global Japanese Encephalitis Vaccine Sales YoY Growth (2021-2032) & (k doses) Figure 9. Yellow Fever Vaccine Image Figure 10. Global Yellow Fever Vaccine Sales YoY Growth (2021-2032) & (k doses) Figure 11. Hepatitis Vaccine Image Figure 12. Global Hepatitis Vaccine Sales YoY Growth (2021-2032) & (k doses) Figure 13. Cholera Vaccine Image Figure 14. Global Cholera Vaccine Sales YoY Growth (2021-2032) & (k doses) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (k doses) Figure 17. Global Travelers Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Travelers Vaccines Market Share by Type 2025 VS 2032 Figure 19. North America Travelers Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. North America Travelers Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Europe Travelers Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Europe Travelers Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Travelers Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Travelers Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Latin America Travelers Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Travelers Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Travelers Vaccines Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Travelers Vaccines Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Travelers Vaccines Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Tourists Image Figure 32. Global Tourists Sales YoY Growth (2021-2032) & (k doses) Figure 33. Students Image Figure 34. Global Students Sales YoY Growth (2021-2032) & (k doses) Figure 35. Workers Image Figure 36. Global Workers Sales YoY Growth (2021-2032) & (k doses) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k doses) Figure 39. Global Travelers Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Travelers Vaccines Market Share by Application 2025 VS 2032 Figure 41. North America Travelers Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. North America Travelers Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Europe Travelers Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Europe Travelers Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Travelers Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Travelers Vaccines Sales Market Share in Value by Application in 2025 Figure 47. Latin America Travelers Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Travelers Vaccines Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Travelers Vaccines Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Travelers Vaccines Sales Market Share in Value by Application in 2025 Figure 51. North America Travelers Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 52. North America Travelers Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Travelers Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Travelers Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 56. Europe Travelers Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Travelers Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Travelers Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 60. Asia-Pacific Travelers Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Travelers Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Travelers Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 64. Latin America Travelers Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Travelers Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Travelers Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 68. Middle East and Africa Travelers Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Travelers Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Travelers Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Travelers Vaccines Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Travelers Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Yellow Fever Vaccine
  • Hepatitis Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Tourists
  • Students
  • Workers
  • Others
Companies covered
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Merck
  • Pfizer
  • CNBG
  • Sanofi Pasteur MSD
  • Serum Institute of India
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Travelers Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Travelers Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Travelers Vaccines Market by Type
  6. 1.3.1 Meningococcal Vaccine
  7. 1.3.2 Japanese Encephalitis Vaccine
  8. 1.3.3 Yellow Fever Vaccine
  9. 1.3.4 Hepatitis Vaccine
  10. 1.3.5 Cholera Vaccine
  11. 1.3.6 Other
  12. 1.4 Global Travelers Vaccines Market Size by Type
  13. 1.4.1 Global Travelers Vaccines Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Travelers Vaccines Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Travelers Vaccines Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Travelers Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Travelers Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Travelers Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Travelers Vaccines Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Travelers Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Travelers Vaccines Industry Trends
  2. 2.2 Travelers Vaccines Industry Drivers
  3. 2.3 Travelers Vaccines Industry Opportunities and Challenges
  4. 2.4 Travelers Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Travelers Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Travelers Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Travelers Vaccines Price (2021-2026)
  4. 3.4 Global Travelers Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Travelers Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Travelers Vaccines Company, Product Type & Application
  7. 3.7 Global Travelers Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Travelers Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Travelers Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Travelers Vaccines Tier 1, Tier 2, and Tier 3
4 Travelers Vaccines Regional Status and Outlook
  1. 4.1 Global Travelers Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Travelers Vaccines Historic Market Size by Region
  3. 4.2.1 Global Travelers Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Travelers Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Travelers Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Travelers Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Travelers Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Travelers Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Travelers Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Travelers Vaccines by Application
  1. 5.1 Travelers Vaccines Market by End Users
  2. 5.1.1 Tourists
  3. 5.1.2 Students
  4. 5.1.3 Workers
  5. 5.1.4 Others
  6. 5.2 Global Travelers Vaccines Market Size by End Users
  7. 5.2.1 Global Travelers Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Travelers Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Travelers Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by End Users
  11. 5.3.1 North America Travelers Vaccines Sales Breakdown by End Users (2021-2026)
  12. 5.3.2 Europe Travelers Vaccines Sales Breakdown by End Users (2021-2026)
  13. 5.3.3 Asia-Pacific Travelers Vaccines Sales Breakdown by End Users (2021-2026)
  14. 5.3.4 South America Travelers Vaccines Sales Breakdown by End Users (2021-2026)
  15. 5.3.5 Middle East and Africa Travelers Vaccines Sales Breakdown by End Users (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline
  2. 6.1.1 GlaxoSmithKline Company Information
  3. 6.1.2 GlaxoSmithKline Business Overview
  4. 6.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
  6. 6.1.5 GlaxoSmithKline Recent Developments
  7. 6.2 Sanofi Pasteur
  8. 6.2.1 Sanofi Pasteur Company Information
  9. 6.2.2 Sanofi Pasteur Business Overview
  10. 6.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
  12. 6.2.5 Sanofi Pasteur Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Travelers Vaccines Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Travelers Vaccines Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 CNBG
  26. 6.5.1 CNBG Company Information
  27. 6.5.2 CNBG Business Overview
  28. 6.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CNBG Travelers Vaccines Product Portfolio
  30. 6.5.5 CNBG Recent Developments
  31. 6.6 Sanofi Pasteur MSD
  32. 6.6.1 Sanofi Pasteur MSD Company Information
  33. 6.6.2 Sanofi Pasteur MSD Business Overview
  34. 6.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
  36. 6.6.5 Sanofi Pasteur MSD Recent Developments
  37. 6.7 Serum Institute of India
  38. 6.7.1 Serum Institute of India Company Information
  39. 6.7.2 Serum Institute of India Business Overview
  40. 6.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Serum Institute of India Travelers Vaccines Product Portfolio
  42. 6.7.5 Serum Institute of India Recent Developments
  43. 6.8 Biokangtai
  44. 6.8.1 Biokangtai Company Information
  45. 6.8.2 Biokangtai Business Overview
  46. 6.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biokangtai Travelers Vaccines Product Portfolio
  48. 6.8.5 Biokangtai Recent Developments
7 North America by Country
  1. 7.1 North America Travelers Vaccines Sales by Country
  2. 7.1.1 North America Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Travelers Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Travelers Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Travelers Vaccines Market Size by Country
  6. 7.2.1 North America Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Travelers Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Travelers Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Travelers Vaccines Sales by Country
  2. 8.1.1 Europe Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Travelers Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Travelers Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Travelers Vaccines Market Size by Country
  6. 8.2.1 Europe Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Travelers Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Travelers Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Travelers Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Travelers Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Travelers Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Travelers Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Travelers Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Travelers Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Travelers Vaccines Sales by Country
  2. 10.1.1 South America Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Travelers Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Travelers Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Travelers Vaccines Market Size by Country
  6. 10.2.1 South America Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Travelers Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Travelers Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Travelers Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Travelers Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Travelers Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Travelers Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Travelers Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Travelers Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Travelers Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Travelers Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Travelers Vaccines Value Chain Analysis
  2. 12.1.1 Travelers Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Travelers Vaccines Production Mode & Process
  7. 12.2 Travelers Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Travelers Vaccines Distributors
  10. 12.2.3 Travelers Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst